BackAkari Therapeutics Plc Overview

Akari Therapeutics Plc Accounts Payable

Track Akari Therapeutics Plc's accounts payable ($9.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$9.40M
↓ 19.01% YoYΔ $-2.21M vs prior year quarter

Peer trimmed avg / median

Loading

Akari Therapeutics Plc Accounts Payable History

Loading

Akari Therapeutics Plc vs. peers: Accounts Payable Comparison

Loading

Akari Therapeutics Plc Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Akari Therapeutics Plc (AKTX) FAQ

Akari Therapeutics Plc (AKTX) currently reports a accounts payable of $9.4M as of June 2026. That compares with $12M in the prior-year period — down 19.0% year over year. Use the charts on this page to explore Akari Therapeutics Plc's accounts payable history and peer comparisons.

Akari Therapeutics Plc's accounts payable decreased from $12M to $9.4M — a 19.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akari Therapeutics Plc reported $9.4M in accounts payable as of June 2026. That compares with $12M in the prior-year period — down 19.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akari Therapeutics Plc, and consider following AKTX for alerts when major investors trade the stock.

Akari Therapeutics Plc is classified in the Healthcare sector. On accounts payable, it currently shows $9.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKTX with unrelated industries.